NeuroMetrix, Inc. financial data

Symbol
NURO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1000 Winter Street, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.24K % -26.6%
Quick Ratio 101 % -21.3%
Debt-to-equity 8.66 % +27.3%
Return On Equity -47.1 % -50.3%
Return On Assets -43.3 % -47.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.06M shares +3.68%
Common Stock, Shares, Outstanding 2.05M shares +34.5%
Entity Public Float 6.9M USD -15.7%
Common Stock, Value, Issued 205 USD +34.9%
Weighted Average Number of Shares Outstanding, Basic 1.97M shares +89%
Weighted Average Number of Shares Outstanding, Diluted 1.97M shares +89%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 1.35M USD -30.7%
Research and Development Expense 1.79M USD -35.5%
Selling and Marketing Expense 2.34M USD -30.5%
General and Administrative Expense 6.33M USD +27.8%
Operating Income (Loss) -8.78M USD -22.8%
Nonoperating Income (Expense) 976K USD +56.9%
Net Income (Loss) Attributable to Parent -7.81M USD -19.6%
Earnings Per Share, Basic -3.96 USD/shares +36.8%
Earnings Per Share, Diluted -3.96 USD/shares +36.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.43M USD -17.6%
Cash, Cash Equivalents, and Short-term Investments 13.1M USD -27.2%
Accounts Receivable, after Allowance for Credit Loss, Current 193K USD -62.8%
Inventory, Net 1.35M USD -13.6%
Assets, Current 15M USD -28%
Property, Plant and Equipment, Net 199K USD -32%
Operating Lease, Right-of-Use Asset 111K USD -55.5%
Other Assets, Noncurrent 26.4K USD 0%
Assets 15.3M USD -28.5%
Accounts Payable, Current 363K USD +68.6%
Accrued Liabilities, Current 542K USD -38.2%
Liabilities, Current 1.01M USD -18.4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 1.01M USD -24.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 60.9K USD -74.6%
Retained Earnings (Accumulated Deficit) -218M USD -3.72%
Stockholders' Equity Attributable to Parent 14.3M USD -28.8%
Liabilities and Equity 15.3M USD -28.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.08M USD -85.6%
Net Cash Provided by (Used in) Financing Activities 1.47M USD
Net Cash Provided by (Used in) Investing Activities 138K USD
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 2.05M shares +34.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -472K USD +75.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.43M USD -17.6%
Deferred Tax Assets, Valuation Allowance 8.87M USD +38.2%
Deferred Tax Assets, Gross 8.9M USD +37.4%
Depreciation 10.2K USD -20.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.99M USD -27%
Lessee, Operating Lease, Liability, to be Paid 117K USD -58.5%
Property, Plant and Equipment, Gross 1.03M USD 0%
Operating Lease, Liability, Current 107K USD -27.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 117K USD -29.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 117K USD -29.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 6.09M USD +42.1%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 232M USD +0.96%
Depreciation, Depletion and Amortization 24.9K USD +144%
Deferred Tax Assets, Net of Valuation Allowance 0 USD